LivingGLP1
Study S002535

Restoring Facial Volume After GLP-1 Weight Loss With Radiesse

ClinicalTrials.gov record

Registration

Registration
NCT07419854
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE4
Masking
SINGLE
Status
RECRUITING
Enrollment
48
Start
2026-02-01
Primary completion
2027-08
Lead sponsor
Kalpna Kay Durairaj, MD, FACS
Conditions
Volume Loss (Soft Tissue Ptosis or Atrophy )
Interventions
DEVICE:Hyperdiluted Calcium Hydroxylapatite; DEVICE:Calcium hydroxylapatite; DEVICE:Calcium hydroxylapatite with integral lidocaine
Results posted
FALSE
Individual participant data sharing
YES

Registered primary outcomes

  • Change in Cheek Volume, as quantified by Quantificare's LifeViz Software [Up to 6 months]
  • Change in Jowl Volume, as quantified by Quantificare's LifeViz Software [Up to 6 months]
  • Change in Nasolabial Fold Depth, as quantified by Quantificare's LifeViz Software [Up to 6 months]
  • Change in Marionette Line Depth, as quantified by Quantificare's LifeViz Software [Up to 6 months]
  • Body Mass Index (BMI) [Up to 12 months]
  • Global Aesthetic Improvement Scale (GAIS) for Global Facial Aesthetic Appearance [Up to 6 months]
  • Global Aesthetic Improvement Scale (GAIS) for Skin Quality [Up to 6 months]
  • Global Aesthetic Improvement Scale (GAIS) for Skin Radiance [Up to 6 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.